Takayasu Kurata

机构：Kansai Medical University · ORCID：0000-0003-4123-3567

发表论文 459 篇 · 总被引 36719 次 · h-index 60

代表论文

Pharmacokinetics and bioavailability of pembrolizumab with berahyaluronidase alfa for subcutaneous administration in participants with advanced or metastatic solid tumors: The phase 1 study 3475A-C18 (2025 · European Journal of Cancer · 被引 7)
Combined effects of slow movement training with tonic force generation and aerobic exercise prior to cancer therapy in patients with lung cancer (START-lung): a pilot feasibility trial (2025 · BMC Cancer · 被引 3)
PD-L1 phenotype classification based on expression in tumor and immune cells as a potential biomarker for optimizing anti-PD-1/CTLA-4 immunotherapies in NSCLC (2025 · Journal for ImmunoTherapy of Cancer · 被引 2)
P3.18.61 KRYSTAL-4: Phase 3 Study of Adagrasib Plus Pembrolizumab and Chemotherapy Intreatment-Naïve, Advanced KRAG12C-Mutated NSCLC (2025 · Journal of Thoracic Oncology · 被引 2)
Exploratory analysis of associations among weight loss, oral function, and dysgeusia in patients with lung cancer undergoing chemotherapy (2025 · BMC Oral Health · 被引 1)
Anamorelin in Cancer Cachexia: Gut Microbiota Effects and CONUT Score as a Predictor of Response (2025 · In Vivo · 被引 1)